Common Variable Immunodeficiency (CVID): Clinical Trials

1 trial for Common Variable Immunodeficiency (CVID), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Common Variable Immunodeficiency (CVID): new trials by email Literature Review of Common Variable Immunodeficiency (CVID) trials Research Report on Common Variable Immunodeficiency (CVID)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Leniolisib for Immune Dysregulation in CVID
Leniolisib - Common Variable Immunodeficiency (CVID)
Phase 2CompletedPharming Technologies B.V.272025-02-122026-09-18

Narrower conditions

Common Variable Immunodeficiency (1)

Broader conditions

Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)

Interventions

leniolisib (1)

Sponsors

Pharming Technologies B.V. (1)

Countries

Spain (1)  ·  United Kingdom (1)  ·  United States (1)